PubMed COVID-19 Clinical Care
8101 - 8110 of 57753 results found
Preoperative Risk Factors and Postoperative Complications of COVID-positive Children Requiring Urgent or Emergent Surgical Care
Description
CONCLUSIONS: Despite increased preoperative risk factors, COVID-positive children did not have an increased risk of postoperative complications after common urgent and emergent procedures. However, length of stay was greater for COVID-positive
Offline: Boris Johnson and COVID-19-more light than heat
Description
No abstract
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2
Description
The upper airways represent the point of entrance from where Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection spreads to the lungs. In the present work, α-tocopheryl-polyethylene-glycol succinate (TPGS) micelles loaded with
Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial
Description
CONCLUSIONS: This data suggests LGG is associated with prolonged time to COVID-19 infection, reduced incidence of illness symptoms, and gut microbiome changes when used as prophylaxis ≤7 days post-COVID-19 exposure, but not overall incidence. This
Understanding poverty through virtual simulation: implications for student clinical practice
Description
CONCLUSIONS: The use of virtual poverty simulation with baccalaureate nursing students was identified as useful pedagogy for increasing student understanding of health implications related to poverty in a virtual learning environment.
Cloth face masks are still useful in preventing COVID-19 transmission in Indonesia
Description
No abstract
Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity
Description
Drug repositioning is critical to drug development. Previous drug repositioning methods mainly constructed drug-disease heterogeneous networks to extract drug-disease features. However, these methods faced difficulty when we are using structurally
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation
Description
Reports of symptomatic rebound and/or test re-positivity among COVID-19 patients following the standard five-day treatment course of nirmatrelvir/ritonavir have sparked debates regarding optimal treatment timing and dosage. It is unclear whether
Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination
Description
CONCLUSIONS: The factors identified in association with the NA level post-vaccination may help to evaluate the protective effect, risk of re-infection, the severity of symptoms, and prognosis for vaccine recipients in clinical.
